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Accepted 29 July 2011AbstractObjectives: To develop a diagnostic platform for preimplantation genetic diagnosis (PGD) and prenatal genetic diagnosis (PND) to prevent births
of aromatic L-amino acid decarboxylase deficiency (AADC) patients.
Materials and Methods: Five Taiwanese families carrying AADC were enrolled. A novel technique, amplification refractory mutation system-
quantitative polymerase chain reaction (ARMS-qPCR), was developed for both of PGD and PND. For PGD, blastomere biopsies of day-3
cleavage-stage embryos were subjected to ARMS-qPCR. Villi, cultured amniocytes, or both were used to confirm the PGD result; this
approach could also be used as the sole method for PND after in vivo conception).
Results: Unaffected live births were achieved in four of the five families, except one with ongoing PGD. The ARMS-qPCR correctly classified
blastomeres (from day-3 cleavage-stage embryos) as affected (homozygous mutant), carrier (heterozygous for mutant and wild-type alleles), or
normal (homozygous wild-type) within 1 working day.
Conclusions: To our knowledge, this is the first report of successful PGD of AADC. The molecular technique we devised (ARMS-qPCR) was
applicable for PGD as well as PND of AADC. Furthermore, it has great potential for similar applications in other monogenic disorders.
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Prenatal diagnosis and genetic counseling are essential for
at-risk couples who wish to avoid giving birth to children
with an inherited disorder. Preimplantation genetic diagnosis
(PGD), used in association with some reproductive technolo-
gies, e.g., in vitro fertilization (IVF), can determine the genetic
makeup of embryos before implantation, and thus minimize
the possibility of an affected pregnancy. Therefore, PGD is an
alternative to prenatal diagnosis (PND) and has become
a feasible option for couples at risk for any one of several
familial genetic disorders [1].
The aromatic L-amino acid decarboxylase deficiency
(AADC; MIM #608643) is a rare inborn error of neurotrans-
mitter metabolism that causes severe developmental delays, an
oculogyric crisis, and autonomic dysfunction. Defects in the
DDC gene (located in 7p12.1p12.3), cause this condition [2].
A Taiwanese couple, with a history of three neonatal deaths
and two induced abortions due to AADC, requested IVF and
PGD to achieve an unaffected pregnancy. Based on a prelimi-
nary molecular evaluation, this couple had identical hetero-
zygous mutations in DDC, IVS6þ 4A>T (a hotspot reported
in more than 80% of Taiwanese patients; a founder effect has
been proposed) [3]. So far, about 30 DDC mutants were
described in no more than 50 AADC cases worldwide [4].
However, apparently no successful PGD for AADC had been
reported. Therefore, we developed and applied a technique,
namely amplification refractory mutation system-polymerase
chain reaction (ARMS-qPCR), for PGD in carrier parents
with a DDC mutation that causes AADC. To confirm and
extend the clinical application of the ARMS-qPCR, the tech-
nique was adapted for PGD and PND, and used in five AADC
families.
The technique involved two technologies. The first was
ARMS-PCR, a PCR-based method that can detect single base-
pair changes or small insertions or deletions, based upon
sequence-specific primer sets [5]. That this method enables
amplification of test DNA only when the target allele is con-
tained within the sample, makes it especially suitable for PGD.
However, such PCR-based technologies are prone to errors,
e.g., contamination or allelic dropout (ADO; only one of two
alleles in a heterozygous cell was amplified, resulting in
misdiagnosis) [6]. Therefore, the second technology, real-time
quantitative PCR (qPCR), was used to minimize errors. The
qPCR is a highly sensitive technique for differential allele
detection in single cells [7]; it can accurately quantify the
number of copies of a particular amplicon, and determine the
ratio of mutant to wild-type alleles in a sample.
Materials and methodsfi
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c.During 2009e2011, five Taiwanese families with AADC
(CCH001eCCH005) who came to our clinic for PGD, PND,
or both, were enrolled in this study. The relevant clinical and
genotypic information are summarized (Table 1) and family
470 S.-J. Kuo et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 468e473pedigrees and genotypes are shown (Fig. 1). PGD was per-
formed in family CCH001 and is now ongoing in family
CCH005, whereas PND was used for families CCH002e
CCH004.Fig. 1. Pedigrees with DDC mutations in five families with aromatic L-amino acid
CCH003 and CCH004) carried the same mutation (IVS6þ 4A>T). (B) Parents of
c.1297dupA). (C) Parents of CCH005 also carried two heterozygous mutations
mutation position.Mutation analysisThe DNA was extracted from single blastomeres biopsied
from day-3 (8-cell cleavage-stage) embryos with gooddecarboxylase deficiency (AADC). (A) Parents from three families (CCH001,
CCH002 carried two heterozygous mutations (paternal: c.1234C>T; maternal:
(paternal: c.1297dupA; maternal: IVS6þ 4A>T). Black arrows indicate the
471S.-J. Kuo et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 468e473morphology (for PGD) and from fetal cells by chorionic
villus sampling at 11e14 weeks of pregnancy (for PND),
using the Genomic DNA Mini Kit (Geneaid, Tao-Yuan,
Taiwan). Furthermore, DNA from peripheral lymphocytes of
reference individuals, including parents, was also extracted
and examined.
All 14 exons of the DDC gene were amplified by poly-
merase chain reaction (PCR), with the corresponding intronic
primers designed from the available genomic DNA sequence
(NCBI Reference Sequence: NG_008742.1) using Oligo 6.71
(Molecular Biology Insights, Cascade, CO, USA). Amplified
fragments were subjected to bidirectional sequencing with the
Big-Dye Terminator v3.1 Cycle Sequencing Kit and ABI
Prism 3100 genetic analyzer (Applied Biosystems, Foster City,
CA, USA).ARMS-qPCRFor PGD, ARMS-qPCR was first evaluated in 20 lympho-
cytes isolated from a fully affected patient and the carrier
couple, respectively, and from 15 single blastomeres obtained
from a cell bank (as normal controls). Subsequently, five
single blastomeres biopsied from five embryos with good
morphology at day 3 (8-cell cleavage-stage) from the carrier
couple were examined. Each blastomere was independently
collected in a sterile PCR tube, lysed with proteinase K
(125 mg/mL in 17 mM SDS; Sigma-Aldrich, St. Louis, MO,
USA) at 50 C, 60 minutes, and inactivated at 99 C, 4
minutes. Duplex-nested PCR was then used to amplify the
intron 5-6 region of DDC, which includes the targeted muta-
tion. The two primer sets, designed based on the reverse
strand’s DDC gene sequence, were OF: 50-CCTCCTGGCTG
GTTTCTTTC-30 and OR: 50-CAGGCACTGTTTCAGGAG
CTA-30 for the first PCR (1,164 bp), and IF: 50-AGGGTCTC
GCCACTTATCCT-30 and IR: 50-TAAGGCAGGGATTCAA
ATGG-30 for the secondary PCR (1,005 bp; Fig. 2A). The first
PCR was carried out in a 40 mL reaction, consisting of
1 PCR buffer, 1.25 mmol/L MgCl2, 0.35 mmol/L dNTP,
0.5 mmol/L of each primer (OFþOR), 1GC-RICH solu-
tion, and 1U Faststart Taq DNA polymerase (Roche Diag-
nostics GmbH, Mannheim, Germany). The cycling conditions
were 95 C, 5 minutes, followed by 25 cycles of 95 C, 30
seconds, 55 C, 30 seconds and 71 C, 1 minute, and a final
extension at 71 C, 2 minutes. The PCR products were directly
subjected to a second round of PCR by adding 10 mL PCR
supplement with a similar PCR mixture to that used in the first
PCR, except for the primer set (IFþ IR). Cycling conditions
were similar to the first PCR, but the number of cycles in the
second step was increased from 25 to 40. To ensure accuracy
of the PCR, amplified fragments were confirmed by direct
sequencing. For ARMS-qPCR, two sequence-specific forward
primers, modified with a mismatch at the penultimate nucle-
otide position of the mutation site to increase the specificity of
the reaction [5], were designed: (MUF: 50-GGCCTGATTCC
TTTCTTTGTGT-30 for the mutant allele and WTF: 50-
GGCCTGATTCCTTTCTTTGTGA-30 for the wild-type
allele). The two forward primers were respectively pairedwith the same reverse primer 3R: 50-CTGCCTCAGCTT
CCCGAGTA-30 (and produced an equivalent 148 bp). The
ARMS-qPCR, performed on the 7700 ABI Prism Sequence
Detector (Applied Biosystems) in a 20 mL reaction, consisted
of 0.5 ng of the duplex-nested PCR product, 0.5 mmol/L of
each primer, 1 ROX, and 1 SYBR Green PCR Master Mix
(Finnzymes, Espoo, Finland). Cycling conditions were: 95 C,
15 minutes, followed by 45 cycles at 95 C, 10 seconds, 60 C,
20 seconds, and 71 C, 10 seconds (Fig. 2B). The condition
and primer sets of ARMS-qPCR used for PND were similar to
those used in PGD.
ResultsAADC familiesFour of the five families (CCH001-CCH004) enrolled in
our study had at least one successful live birth of an unaffected
child (Table 1). Three families received PND, either by cho-
rionic villus sampling or amniocentesis after natural concep-
tion (CCH002eCCH004). One couple, which had two
consecutive induced abortions due to affected pregnancies
ascertained by PND after natural conception, requested PGD
(CCH001) and eventually had an unaffected live birth (Table 1
and Fig. 1).ARMS-qPCR and PGD in family CCH001The PCR amplification rate of the 60 single lymphocytes
and the 15 single blastomeres was 100% (60/60) and 93%
(14/15), respectively. Direct sequencing of the PCR products
confirmed that the accuracy of the ARMS-qPCR was 100%
(74/74). In the 40 heterozygous lymphocytes (from the
couple), there was no evidence of ADO in the ARMS-qPCR
(the heterozygous curves from the ARMS-qPCR almost
overlapped), suggesting that the amplification efficiencies for
the mutant and the wide-type alleles were similar (Fig. 2C).
Of the five single blastomeres requested for clinical PGD,
two were confirmed unaffected: one was homozygous
wide-type, whereas the other was a heterozygous carrier.
The two embryos corresponding to the two unaffected
blastomeres were selected for implantation (informed
consent) at day 5. A successful singleton pregnancy was
eventually achieved. After 38 weeks of uneventful gestation,
the woman gave birth to a healthy male baby (birth body
weight 3180 g, birth body length 50 cm, and AS 80-> 90),
whose postnatal genotyping confirmed the results of PGD
and amniocentesis.
DiscussionAADCThere were only four mutant genotypes in the five Taiwa-
nese families (10 heterozygous carrier individuals) enrolled in
our study, including IVS6þ 4A>T (n¼ 7), c.1234C>T
(n¼ 1), and c.1297dupA (n¼ 2). The prevalent IVS6þ 4A>T
Fig. 2. Schematic diagram of a duplex-nested amplification refractory mutation system quantitative polymerase chain reaction (ARMS-qPCR) for PGD of the
IVS6þ 4A>T point mutation in the DDC gene. (A) Duplex-nested PCR was used to amplify the region from DDC intron 5 to intron 6, including the position of the
IVS6þ 4A>T mutation (*). The primers were designed using the reverse-strand sequence. OF and OR, outer primer set; IF and IR, inner primer set. (B) ARMS-
qPCR to separate mutant and wild-type alleles. WTF and MUF, two primers specific for amplification of wild-type (WT) and mutant (MU) alleles, respectively. (C)
A representative ARMS-PCR experiment for the following genotypes: WT/WT (including a normal control [C1] and an examined blastomere [BM1]), WT/MU
(including one of the carrier parents [C2] and another examined blastomere [BM2]), and MU/MU (an affected individual lymphocyte control [C3]). M¼marker.
The result of the DN-ARMS-qPCR is shown at the bottom. PCR tests with WT allele-specific primers are indicated by red and green lines (duplication), whereas
PCR tests with MU allele-specific primers are indicated by blue and yellow lines (duplication).
472 S.-J. Kuo et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 468e473mutant allele may be the consequence of a founder effect [3].
The fact that currently available medical treatments for this
condition have poor efficacy [3] justifies the use of PND and
PGD in this population.ARMS-qPCR for PGDTo our knowledge, the ARMS method has so far been used
for PGD in only a few conditions, e.g., single allele-specific
473S.-J. Kuo et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 468e473ARMS in spinal muscular atrophy and double allele-specific
ARMS in adenomatous polyposis [8,9]. In contrast to
a single-ARMS test, where only one mutation-specific primer
is used, our ARMS was based on a double allele-specific
approach, thereby allowing discrimination of wild-type and
mutated alleles. Well-known approaches were adapted to
minimize misdiagnosis. Most PCR-based technologies used
for PGD, e.g., restriction fragment length polymorphism
(RFLP) [10] and primer extension mini-sequencing [11], rely
on “endpoint” qualitative analysis. These methods can only
assess the presence or absence of mutant and wild-type alleles,
but cannot determine whether contamination or ADO occurred.
In contrast, using real-time qPCR and monitoring PCR
amplification, (especially reaction kinetics in the early phases
of qPCR), facilitated correctly classifying the three genotypic
combinations (wild-type/wild-type, wild-type/mutant, and
mutant/mutant, [Fig. 2C]). In addition, contamination or ADO
could be detected by assessing quantitative curves throughout
the PCR process.
Recently, some real-time PCR technologies based on the
principle of fluorescent resonance energy transfer (FRET)
have been developed for single-cell genotyping with
fluorescence-labeled FRET probes, and deemed useful as PGD
methods [12]. However, designing the FRET probes increases
costs. In that regard, ARMS-qPCR uses SYBR Green, a fluo-
rescent dye that binds to the minor groove of double-stranded
DNA, rather than fluorescent dye-labeled primers, making
future PGD experiments easier and cheaper. Although the total
time required for each experiment depends on the number of
blastomeres sent for analysis, an optimized protocol should
require less than 1 working day to accomplish the PGD. The
ARMS-qPCR has many advantages for application in PGD,
but it was suggested that cases requested for such customized
design should be tested with linkage analysis to decrease the
risk of misdiagnosis caused by extreme preferential amplifi-
cation of one allele or ADO [13,14].
In conclusion, we report the first successful PGD of AADC
using ARMS-qPCR. The initial step of duplex-nested PCR
enabled the creation of specific replicates from a single blas-
tomere in a single tube, reaching the threshold of the amount
of DNA required for further amplification, followed by a novel
ARMS-qPCR, to allow differential amplification of mutant
and wild-type alleles. Given its high amplification rate and
accuracy, ARMS-qPCR is a feasible method for PGD in
couples with known genotypes. We propose that the molecular
technique reported in this study will substantially contribute to
PGA as well as PND of AADC.Acknowledgments
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